These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26050296)

  • 1. Pulmonary nocardiosis in an adolescent patient with Crohn's disease treated with infliximab: a serious complication of TNF-alpha blockers.
    Verma R; Walia R; Sondike SB; Khan R
    W V Med J; 2015; 111(3):36-9. PubMed ID: 26050296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of nocardial infections with anti-tumor necrosis factor therapy.
    Ali T; Chakraburtty A; Mahmood S; Bronze MS
    Am J Med Sci; 2013 Aug; 346(2):166-8. PubMed ID: 23531994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of liver nocardiosis associated with Crohn's disease while treating infliximab].
    Nakahara T; Kan H; Nakahara H; Asamoto Y; Komatsu H; Tokumo H; Ishida K
    Nihon Shokakibyo Gakkai Zasshi; 2011 Apr; 108(4):619-26. PubMed ID: 21467769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous nocardiosis complicating management of Crohn's disease with infliximab and prednisone.
    Singh SM; Rau NV; Cohen LB; Harris H
    CMAJ; 2004 Oct; 171(9):1063-4. PubMed ID: 15505269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Opportunistic co-infection in a patient with Crohn's disease during infliximab (anti-TNFalpha) therapy].
    Salavert M; Bastida G; Pemán J; Nos P
    Rev Iberoam Micol; 2009 Sep; 26(3):213-7. PubMed ID: 19635442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Disseminated tuberculosis following infliximab therapy for Crohn disease: a case report].
    Bouchentouf R; Yasser Z; Aitbenasser MA
    Rev Pneumol Clin; 2014 Dec; 70(6):366-9. PubMed ID: 25131370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated systemic Nocardia farcinica infection complicating alefacept and infliximab therapy in a patient with severe psoriasis.
    Al-Tawfiq JA; Al-Khatti AA
    Int J Infect Dis; 2010 Feb; 14(2):e153-7. PubMed ID: 19501534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience.
    Lawrance IC; Radford-Smith GL; Bampton PA; Andrews JM; Tan PK; Croft A; Gearry RB; Florin TH
    J Gastroenterol Hepatol; 2010 Nov; 25(11):1732-8. PubMed ID: 21039834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune hepatitis induced by infliximab in a patient with Crohn's disease with no relapse after switching to adalimumab.
    Cravo M; Silva R; Serrano M
    BioDrugs; 2010 Dec; 24 Suppl 1():25-7. PubMed ID: 21175232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcoidosis during infliximab therapy for Crohn's disease.
    Takahashi H; Kaneta K; Honma M; Ishida-Yamamoto A; Ashida T; Kohgo Y; Ohsaki Y; Iizuka H
    J Dermatol; 2010 May; 37(5):471-4. PubMed ID: 20536653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Flexural psoriasis induced by infliximab and adalimumab in a patient with Crohn's disease].
    Avila Alvarez A; García-Alonso L; Solar Boga A; García-Silva J
    An Pediatr (Barc); 2009 Mar; 70(3):278-81. PubMed ID: 19409245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab-induced psoriasis during therapy for Crohn's disease.
    Steinwurz F; Denadai R; Saad-Hossne R; Queiroz ML; Teixeira FV; Romiti R
    J Crohns Colitis; 2012 Jun; 6(5):610-6. PubMed ID: 22398095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-TNF-α antibodies improve intestinal barrier function in Crohn's disease.
    Noth R; Stüber E; Häsler R; Nikolaus S; Kühbacher T; Hampe J; Bewig B; Schreiber S; Arlt A
    J Crohns Colitis; 2012 May; 6(4):464-9. PubMed ID: 22398062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of tuberculosis in Korean patients with inflammatory bowel disease receiving tumor necrosis factor-α blockers.
    Byun JM; Lee CK; Rhee SY; Kim HJ; Kim JW; Shim JJ; Jang JY
    J Korean Med Sci; 2015 Feb; 30(2):173-9. PubMed ID: 25653489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ineffectiveness of infliximab therapy in severe infantile Crohn's disease.
    Uslu N; Usta Y; Saltik-Temizel IN; Demir H; Gürakan F; Ozen H; Yüce A
    J Crohns Colitis; 2010 Feb; 4(1):106-9. PubMed ID: 21122492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rash induced by anti-tumor necrosis factor agents in an adolescent with Crohn's disease.
    Conklin LS; Cohen B; Wilson L; Cuffari C; Oliva-Hemker M
    Nat Rev Gastroenterol Hepatol; 2010 Mar; 7(3):174-7. PubMed ID: 20203680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-TNF-alpha treatments and obstructive symptoms in Crohn's disease: a prospective study.
    Condino G; Calabrese E; Zorzi F; Onali S; Lolli E; De Biasio F; Ascolani M; Pallone F; Biancone L
    Dig Liver Dis; 2013 Mar; 45(3):258-62. PubMed ID: 23195667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-TNF antibodies in the treatment of inflammatory intestinal stenoses in Crohn's disease].
    Holtmann M; Wanitschke R; Helisch A; Bartenstein P; Galle PR; Neurath M
    Z Gastroenterol; 2003 Jan; 41(1):11-7. PubMed ID: 12541166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of metastatic Crohn's disease of the skin while on anti-TNF biologics.
    Patel AV; Jones DM; Hill JC; MacDermott RP
    Inflamm Bowel Dis; 2012 Jun; 18(6):1188-90. PubMed ID: 22294342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.